Phase 2 trial of regorafenib in recurrent or metastatic adenoid cystic carcinoma.
Desilets A, Vos JL, Katabi N, Kuo F, Nadeem Z, Linxweiler M, Ostrovnaya I, Baxi S, Dunn LA, Sherman EJ, Pfister DG, Morris LGT, Ho AL.
Desilets A, et al. Among authors: dunn la.
Clin Cancer Res. 2024 Oct 1. doi: 10.1158/1078-0432.CCR-24-1064. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39352719